Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-05

Clinical Trial Update: Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials [Phase 2]

View source ↗

Summary

Phase 2 trial update describing a screening protocol for preliminary eligibility in adoptive cell therapy trials; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GlaxoSmithKline

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2024-02-05